Tobroft 1 mg, 3 mg Eye drops
PDF Leaflet Revision Date: 04 April 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Reduction of ocular inflammation and prophylaxis of infection post-surgery.
Dosage (summary)
1 drop every 4 hours for 3 days pre-surgery; 2 drops every 2 hours for 2 days post-surgery; then 1 drop 4 times daily for 1 week, followed by 1 drop daily for 10 days.
Special Populations
- Paediatric patients
- Patients with glaucoma
Pregnancy & Breastfeeding
Safety in pregnancy not established; caution in breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors may increase effects
- Topical NSAIDs may increase healing problems
Contraindications
- Hypersensitivity to components
- Epithelial herpes simplex keratitis
- Mycobacterial eye infection
- Fungal ocular diseases
- Untreated purulent eye infection
Common side effects
- Eye pain
- Increased intraocular pressure
- Eye irritation
- Eye pruritus
Counselling Points
- Shake well before use
- Avoid contact with soft contact lenses
- Report any visual disturbances
Serious warnings
- Prolonged use may cause glaucoma and cataracts
- Monitor intraocular pressure
- Risk of secondary infections
Important Disclaimer
The Tobroft 1 mg, 3 mg Eye drops professional information leaflet below is the property of Austell Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
